Latest Technology Platform News

Thrive Tribe Technologies has raised approximately $200,000 through a discounted share placement, aiming to bolster working capital and support its health and wellness platform growth.

Adheris Health has received the final $6.1 million holdback payment from its Australian and New Zealand business sale, bringing total proceeds to $33.1 million and setting the stage for future earn-out payments.

Temas Resources has appointed Nic Matich as a Non-Executive Director to spearhead Australian investor relations and business development, while CFO David Robinson transitions to a full-time executive role to sharpen financial oversight amid the company’s growth and commercialisation push.

EPX Limited has successfully raised nearly $295,000 through a Security Purchase Plan, supporting its recent acquisition of Wattwatchers and positioning the company for further expansion.

Guzman y Gomez has secured a multi-year exclusive delivery partnership with Uber Eats in Australia, aiming to accelerate growth and enhance customer convenience. Delivery now accounts for over a quarter of GYG’s Australian sales, underscoring its strategic importance.

Metallium Limited has raised A$75 million in a strategic capital round led by U.S. institutional investors, accelerating its commercial operations in Texas and setting the stage for a NASDAQ listing later this year.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

Alcidion Group has been named preferred supplier for a major UK hospital's Electronic Patient Record system, driving a 40% jump in contracted revenue and a robust cash position in Q2 FY26.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Electro Optic Systems (EOS) has acquired European defence tech firm MARSS, integrating advanced AI-enabled command and control systems to create a comprehensive counter-drone solution. This strategic move positions EOS as a prime contractor for larger defence programs and expands its global footprint.

Eden Innovations has secured a $2.2 million strategic investment to fully repay its remaining iBorrow debt, eliminating costly interest payments and strengthening its balance sheet ahead of anticipated revenue growth.